The Carterra LSA, a high-throughput monoclonal antibody characterization platform, combines microfluidic flow technology and high-throughput surface plasmon resonance detection. The LSA helped AbCellera and Eli Lilly and Company evaluate binding affinity and epitope coverage for over 500 patient-derived antibodies, including LY-CoV555.

Read the Article